Literature DB >> 8764637

Hepatitis C virus--a pathogen for all people.

L Dove, T L Wright.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8764637      PMCID： PMC1303640     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  9 in total

1.  Clinical sequelae of hepatitis C acquired from injection drug use.

Authors:  M J Tong; N S el-Farra
Journal:  West J Med       Date:  1996-05

2.  Interferon and hepatitis C.

Authors:  N Terrault; T Wright
Journal:  N Engl J Med       Date:  1995-06-01       Impact factor: 91.245

3.  Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus.

Authors:  K Kiyosawa; T Sodeyama; E Tanaka; Y Gibo; K Yoshizawa; Y Nakano; S Furuta; Y Akahane; K Nishioka; R H Purcell
Journal:  Hepatology       Date:  1990-10       Impact factor: 17.425

4.  The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses.

Authors:  M Kobayashi; E Tanaka; T Sodeyama; A Urushihara; A Matsumoto; K Kiyosawa
Journal:  Hepatology       Date:  1996-04       Impact factor: 17.425

5.  The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team.

Authors:  M J Alter; H S Margolis; K Krawczynski; F N Judson; A Mares; W J Alexander; P Y Hu; J K Miller; M A Gerber; R E Sampliner
Journal:  N Engl J Med       Date:  1992-12-31       Impact factor: 91.245

6.  Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group.

Authors:  L B Seeff; Z Buskell-Bales; E C Wright; S J Durako; H J Alter; F L Iber; F B Hollinger; G Gitnick; R G Knodell; R P Perrillo
Journal:  N Engl J Med       Date:  1992-12-31       Impact factor: 91.245

7.  Chronic non-A, non-B hepatitis developed after transfusions, illicit self-injections or sporadically. Outcome during long-term follow-up--a comparison.

Authors:  L Mattsson; O Weiland; H Glaumann
Journal:  Liver       Date:  1989-04

8.  Clinical outcomes after transfusion-associated hepatitis C.

Authors:  M J Tong; N S el-Farra; A R Reikes; R L Co
Journal:  N Engl J Med       Date:  1995-06-01       Impact factor: 91.245

9.  The pathology of hepatitis C as a function of mode of transmission: blood transfusion vs. intravenous drug use.

Authors:  S C Gordon; R S Elloway; J C Long; C F Dmuchowski
Journal:  Hepatology       Date:  1993-12       Impact factor: 17.425
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.